Clinical Pharmacology & Model-Informed Drug Development Insights for Targeted Radiation Therapies Blog Post
靶向放射性核素治疗（TRT）通过将细胞毒性辐射选择性作用于肿瘤实现精准治疗。近年来，肿瘤药物开发者对此疗法的关注度显著提升。However, the regulatory landscape is still…
Demystifying CDISC, SDTM, and ADaM Blog Post
拆解 CDISC CDASH/SDTM/ADaM 标准基础概念，解析其核心原理与应用方法，助您掌握标准实施要点。
Certara Appoints New Chief Human Resources Officer & General Counsel Blog Post
RADNOR, PA – 2024 年 5 月 21 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development, has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran…
Leveling Up SDTM Validation with the Magic of Data Managers Blog Post
In this abstract, Julie Ann Hood and Jennifer Manzi look at how you can improve your SDTM Validation with the magic of Data Managers.
Dreaming big with standardization in clinical trial design – one biopharma’s metadata automation journey Blog Post
本案例研究探讨了一家生物制药公司如何通过临床试验设计标准化获得更深入洞察与更明智的决策。
Reflections on the New FDA Clinical Pharmacology Guidance for Antibody-Drug Conjugates Blog Post
In recent years, oncology drug developers have invested in antibody-drug conjugates (ADCs). These targeted therapies deliver cytotoxic small-molecule drug payloads to cancer cells. The cytotoxic payload attaches to a monoclonal…
CERTARA & CLOUDSCIENTIFIC ACCELERATE AI FOR DRUG DEVELOPMENT IN CHINA Blog Post
Partnership will provide biopharmaceutical companies with advanced tools and solutions needed to expedite research RADNOR, PA – 2024 年 5 月 10 日 – Certara, Inc., a global leader in model-informed drug…
